Budget Allocations, Net of Recoveries and Plan Outlay for Ministry of Chemicals and Fertilisers (Department of Pharmaceuticals) in India (2020-2021 to 2022-2023) | ||||||||||||
(Rs. in Crore) | ||||||||||||
Particulars | 2020-2021 (Actual) | 2021-2022 (Budget) | 2021-2022 (Revised) | 2022-2023 (Budget) | ||||||||
Revenue | Capital | Total | Revenue | Capital | Total | Revenue | Capital | Total | Revenue | Capital | Total | |
Gross | ||||||||||||
Recoveries | ||||||||||||
Receipts | ||||||||||||
Net | ||||||||||||
A. The Budget Allocations, Net of Recoveries and Receipts, are Given below | ||||||||||||
Centre's Expenditure | ||||||||||||
Establishment Expenditure of the Centre | ||||||||||||
1. Secretariat | ||||||||||||
2. National Pharmaceutical Pricing Authority (NPPA) | ||||||||||||
Total-Establishment Expenditure of the Centre | ||||||||||||
Central Sector Schemes/Projects | ||||||||||||
3. National Institutes of Pharmaceutical Education and Research (NIPERs) | ||||||||||||
4. Jan Aushadhi Scheme | ||||||||||||
5. Development of Pharmaceutical Industry | ||||||||||||
6. Consumer Awareness Publicity and Price Monitoring | ||||||||||||
Development of Pharmaceutical Industry | ||||||||||||
7. Development of Pharmaceutical Indsutry | ||||||||||||
(i) Pharmaceutical Promotion & Development Scheme (PPDS) | ||||||||||||
(ii) Assistance to Pharmaceutical Industry for Common Facilities(API-CF)/Cluster Development | ||||||||||||
(iii) Pharmaceuticals Technology Upgradation Assistance Scheme (PTUAS) | ||||||||||||
Total- Development of Pharmaceutical Indsutry | ||||||||||||
Production Linked Incentive Schemes | ||||||||||||
8. Production Linked Incentive Schemes | ||||||||||||
(i) Promotion of Bulk Drug Parks | ||||||||||||
(ii) Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India | ||||||||||||
(iii) Promotion of Medical Device Parks | ||||||||||||
(iv) Production Linked Incentive (PLI) Scheme for Domestic Manufacturing of Medical Devices | ||||||||||||
(v) Production Linked Incentive Scheme for Pharmaceuticals | ||||||||||||
Total- Production Linked Incentive Schemes | ||||||||||||
Total-Central Sector Schemes/Projects | ||||||||||||
Other Central Sector Expenditure | ||||||||||||
Autonomous Bodies | ||||||||||||
9. National Institute of Pharmaceutical Education and Reaserch (NIPERs) | ||||||||||||
Public Sector Undertakings | ||||||||||||
10. Assistance to PSUs | ||||||||||||
11. Write Off/Waiver of losses in respect of Pharmaceuticals PSUs | ||||||||||||
(i) India Drugs and Pharmaceuticals Limited (IDPL) | ||||||||||||
Net | ||||||||||||
(ii) Bengal Chemicals & Pharmaceuticals Limited (BCPL) | ||||||||||||
Net | ||||||||||||
Net | ||||||||||||
Total-Public Sector Undertakings | ||||||||||||
Total-Other Central Sector Expenditure | ||||||||||||
Transfers to State | ||||||||||||
Other Grants/Loans/Transfers | ||||||||||||
12. Recovery | ||||||||||||
Grand Total | ||||||||||||
B. Developmental Heads | ||||||||||||
Economic Services | ||||||||||||
1. Industries | ||||||||||||
2. Secretariat-Economic Services | ||||||||||||
3. Loans for Chemical and Pharmaceutical Industries | ||||||||||||
Total-Economic Services | ||||||||||||
Others | ||||||||||||
4. North Eastern Areas | ||||||||||||
Total-Others | ||||||||||||
Grand Total | ||||||||||||
C. Investment in Public Enterprises | ||||||||||||
1. Karnataka Antibiotics and Pharmaceuticals Ltd | ||||||||||||
2. Indian Drugs and Pharmaceuticals Ltd | ||||||||||||
3. Hindustan Antibiotics Ltd | ||||||||||||
4. Bengal Chemicals and Pharmaceuticals Ltd | ||||||||||||
5. Bengal Immunity Ltd | ||||||||||||
6. Rajasthan Drugs and Pharmaceuticals Ltd | ||||||||||||
7. Smith Stanistreet Pharmaceuticals Ltd | ||||||||||||
Total |